Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.American Journal of Hematology|June 13, 1998
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemiaM Montillo, S Mirto, M C Petti, et al.Leukemia & Lymphoma|February 1, 1993
Bisantrene in relapsed and refractory acute myelogenous leukemiaA Spadea, M C Petti, M A Aloespiriti, et al.Leukemia|May 17, 2003
Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimenC Girmenia, F Lo Coco, M Breccia, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.British Journal of Haematology|May 1, 1990
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patientsG Visani, C Finelli, U Castelli, et al.Leukemia|May 1, 1993
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary resultsM C Petti, F Mandelli, V Zagonel, et al.British Journal of Haematology|February 19, 2002
Melphalan treatment in patients with myelofibrosis with myeloid metaplasiaM C Petti, R Latagliata, T Spadea, et al.Haematologica|August 28, 2001
Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remissionF Ferrara, F Morabito, R Latagliata, et al.Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.Pageof 5